May 15, 2018
Cipher Pharmaceuticals Completes Acquisition of Canadian Business Portfolio of Cardiome Pharma
May 15, 2018
Correvio Pharma Corp Completes Strategic Transaction with Cipher Pharmaceuticals
May 11, 2018
Cipher Pharmaceuticals Reports Voting Results for the Election of Directors
May 01, 2018
Notice of Cipher Pharmaceuticals Q1 2018 Conference Call & Annual Meeting
Apr 26, 2018
Cipher Pharmaceuticals Proposes Adding Dr. Laurence Terrisse-Rulleau To Board of Directors
Apr 23, 2018
Cipher Pharmaceuticals Provides Corporate Update and Preliminary Q1 2018 Revenue Results
Apr 06, 2018
Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to U.S. FDA-Approved A-101 40% Topical Solution from Aclaris Therapeutics
Mar 20, 2018
Cipher Pharmaceuticals and Cardiome Pharma Announce Strategic Transaction for Canadian Business Portfolio of Cardiome
Feb 28, 2018
Cipher Pharmaceuticals Reports Q4 & FY2017 Results
Feb 28, 2018
Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to FDA-Approved TRULANCE® from Synergy Pharmaceuticals
Jan 09, 2018
Cipher Pharmaceuticals and Italmex Pharma Announce Exclusive Distribution Agreement for Isotretinoin Product in Mexico
Jan 08, 2018
Cipher Pharmaceuticals Announces Canadian Launch of OZANEX(TM) (ozenoxacin cream 1%), a Novel Topical Antibiotic
Nov 03, 2017
Cipher Pharmaceuticals Announces New Credit Facility
Nov 03, 2017
Cipher Pharmaceuticals Reports Q3 2017 Operating & Financial Results
Oct 17, 2017
/C O R R E C T I O N from Source -- Cipher Pharmaceuticals Inc./
Oct 10, 2017
Cipher Pharmaceuticals Comments on Supply Chain Impact from Hurricane Maria
Sep 07, 2017
Cipher Pharmaceuticals Comments on FDA Warning Letter for ConZip® (Tramadol)
Aug 11, 2017
Cipher Pharmaceuticals reports Q2 2017 financial results
Jul 25, 2017
Notice of Cipher Pharmaceuticals Q2 2017 Conference Call
Jun 02, 2017
Cipher Pharmaceuticals Adds New Vice President of Corporate Development